Invention Grant
- Patent Title: Substituted pyrimidinyl oxime kinase inhibitors
- Patent Title (中): 取代的嘧啶基肟激酶抑制剂
-
Application No.: US13406822Application Date: 2012-02-28
-
Publication No.: US08367825B2Publication Date: 2013-02-05
- Inventor: Xu Guozhang , Lily Lee , Terry V. Hughes , Steven K. Wetter , Peter J. Connolly , Marta C. Abad , Stuart L. Emanuel , Prabha S. Kamachi , Steven A. Middleton , Kathleen A. Battista , Gilles C. Bignan
- Applicant: Xu Guozhang , Lily Lee , Terry V. Hughes , Steven K. Wetter , Peter J. Connolly , Marta C. Abad , Stuart L. Emanuel , Prabha S. Kamachi , Steven A. Middleton , Kathleen A. Battista , Gilles C. Bignan
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica N.V.
- Current Assignee: Janssen Pharmaceutica N.V.
- Current Assignee Address: BE Beerse
- Agency: Woodcock Washburn LLP
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07D239/50 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D403/14 ; A61K31/505 ; A61K31/506 ; A61P19/02
Abstract:
The present invention is directed to substituted pyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
Public/Granted literature
- US20120157412A1 Substituted Pyrimidinyl Oxime Kinase Inhibitors Public/Granted day:2012-06-21
Information query
